Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $207.07 million. The enterprise value is $175.62 million.
| Market Cap | 207.07M |
| Enterprise Value | 175.62M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 80.57 million shares outstanding. The number of shares has decreased by -2.61% in one year.
| Current Share Class | 80.57M |
| Shares Outstanding | 80.57M |
| Shares Change (YoY) | -2.61% |
| Shares Change (QoQ) | -0.59% |
| Owned by Insiders (%) | 3.88% |
| Owned by Institutions (%) | 24.68% |
| Float | 77.45M |
Valuation Ratios
The trailing PE ratio is 10.87.
| PE Ratio | 10.87 |
| Forward PE | n/a |
| PS Ratio | 2.57 |
| Forward PS | 3.37 |
| PB Ratio | 2.90 |
| P/TBV Ratio | 2.90 |
| P/FCF Ratio | 27.00 |
| P/OCF Ratio | 20.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.06, with an EV/FCF ratio of 22.90.
| EV / Earnings | 9.27 |
| EV / Sales | 2.18 |
| EV / EBITDA | 7.06 |
| EV / EBIT | 7.54 |
| EV / FCF | 22.90 |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.94 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 1.20 |
| Interest Coverage | 18.97 |
Financial Efficiency
Return on equity (ROE) is 31.23% and return on invested capital (ROIC) is 58.24%.
| Return on Equity (ROE) | 31.23% |
| Return on Assets (ROA) | 15.42% |
| Return on Invested Capital (ROIC) | 58.24% |
| Return on Capital Employed (ROCE) | 29.50% |
| Weighted Average Cost of Capital (WACC) | 4.06% |
| Revenue Per Employee | $356,721 |
| Profits Per Employee | $83,827 |
| Employee Count | 226 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, PLX has paid $4.52 million in taxes.
| Income Tax | 4.52M |
| Effective Tax Rate | 19.26% |
Stock Price Statistics
The stock price has increased by +20.09% in the last 52 weeks. The beta is -0.09, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | +20.09% |
| 50-Day Moving Average | 2.62 |
| 200-Day Moving Average | 2.40 |
| Relative Strength Index (RSI) | 43.50 |
| Average Volume (20 Days) | 926,681 |
Short Selling Information
The latest short interest is 3.04 million, so 3.77% of the outstanding shares have been sold short.
| Short Interest | 3.04M |
| Short Previous Month | 3.17M |
| Short % of Shares Out | 3.77% |
| Short % of Float | 3.93% |
| Short Ratio (days to cover) | 4.16 |
Income Statement
In the last 12 months, PLX had revenue of $80.62 million and earned $18.95 million in profits. Earnings per share was $0.24.
| Revenue | 80.62M |
| Gross Profit | 36.90M |
| Operating Income | 23.29M |
| Pretax Income | 23.46M |
| Net Income | 18.95M |
| EBITDA | 24.86M |
| EBIT | 23.29M |
| Earnings Per Share (EPS) | $0.24 |
Balance Sheet
The company has $40.66 million in cash and $9.21 million in debt, with a net cash position of $31.45 million or $0.39 per share.
| Cash & Cash Equivalents | 40.66M |
| Total Debt | 9.21M |
| Net Cash | 31.45M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | 71.40M |
| Book Value Per Share | 0.89 |
| Working Capital | 60.83M |
Cash Flow
In the last 12 months, operating cash flow was $9.92 million and capital expenditures -$2.26 million, giving a free cash flow of $7.67 million.
| Operating Cash Flow | 9.92M |
| Capital Expenditures | -2.26M |
| Depreciation & Amortization | 1.57M |
| Net Borrowing | n/a |
| Free Cash Flow | 7.67M |
| FCF Per Share | $0.10 |
Margins
Gross margin is 45.77%, with operating and profit margins of 28.89% and 23.50%.
| Gross Margin | 45.77% |
| Operating Margin | 28.89% |
| Pretax Margin | 29.10% |
| Profit Margin | 23.50% |
| EBITDA Margin | 30.84% |
| EBIT Margin | 28.89% |
| FCF Margin | 9.51% |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.61% |
| Shareholder Yield | 2.61% |
| Earnings Yield | 9.20% |
| FCF Yield | 3.70% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 9.28% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PLX has an Altman Z-Score of 0.03 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.03 |
| Piotroski F-Score | 6 |